US Stock MarketDetailed Quotes

Barinthus Biotherapeutics (BRNS)

Watchlist
  • 0.7280
  • +0.0180+2.54%
Close Jan 22 15:13 ET
29.72MMarket Cap-0.39P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Barinthus Biotherapeutics (BRNS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
1,766.46%14.97M
0
14.97M
0
0
-98.21%802K
0
Operating revenue
--0
--0
--0
1,766.46%14.97M
--0
--14.97M
--0
--0
-98.21%802K
--0
Cost of revenue
Gross profit
Operating expense
-57.21%10.16M
24.95%21.98M
24.38%20.3M
-17.85%66.75M
-53.24%9.09M
59.34%23.74M
-32.62%17.59M
-21.52%16.32M
71.05%81.26M
-38.18%19.45M
Selling and administrative expenses
-61.51%5.17M
113.64%15.38M
110.86%12.64M
-25.53%29.67M
-77.56%3.06M
1,296.46%13.42M
-45.15%7.2M
-50.62%5.99M
523.12%39.84M
-29.69%13.62M
-General and administrative expense
-61.51%5.17M
113.64%15.38M
110.86%12.64M
-25.53%29.67M
-77.56%3.06M
1,296.46%13.42M
-45.15%7.2M
-50.62%5.99M
523.12%39.84M
-29.69%13.62M
Research and development costs
-51.10%5.15M
-39.73%6.61M
-24.15%7.99M
-7.63%38.25M
6.67%6.22M
-24.45%10.53M
-15.52%10.97M
21.65%10.53M
0.74%41.41M
-51.77%5.83M
Other operating expenses
25.71%-156K
97.75%-13K
-60.49%-329K
---1.18M
---184K
---210K
---577K
---205K
----
----
Operating profit
-15.81%-10.16M
-24.95%-21.98M
-24.38%-20.3M
35.64%-51.78M
53.24%-9.09M
41.13%-8.77M
31.75%-17.59M
19.71%-16.32M
-2,772.30%-80.45M
22.22%-19.45M
Net non-operating interest income expense
-25.24%459K
-17.98%511K
-28.83%543K
-7.86%2.63M
10.82%625K
224.87%614K
22.64%623K
-51.95%763K
-7.62%2.85M
-56.78%564K
Non-operating interest income
-25.20%472K
-17.64%523K
-28.26%556K
-6.92%2.68M
11.56%637K
221.94%631K
21.65%635K
-51.20%775K
-7.28%2.88M
-56.87%571K
Non-operating interest expense
-23.53%13K
0.00%12K
8.33%13K
89.29%53K
71.43%12K
142.86%17K
-14.29%12K
--12K
47.37%28K
--7K
Other net income (expense)
-19,107.69%-4.94M
1,500.00%320K
75K
-1,215.90%-12.07M
-1,665.89%-12.12M
1,400.00%26K
-93.55%20K
90.83%1.08M
50.00%774K
Special income (charges)
---4.67M
----
----
---12.21M
---12.21M
--0
----
----
--0
----
-Less:Impairment of capital assets
--4.67M
----
----
--12.21M
--12.21M
--0
----
----
--0
----
Other non- operating income (expenses)
-1,157.69%-275K
1,500.00%320K
--75K
-87.52%135K
-88.50%89K
1,400.00%26K
-93.55%20K
----
90.83%1.08M
50.00%774K
Income before tax
-80.05%-14.64M
-24.78%-21.15M
-26.50%-19.68M
19.99%-61.23M
-13.68%-20.59M
44.73%-8.13M
32.09%-16.95M
16.98%-15.56M
-9,102.59%-76.52M
21.88%-18.11M
Income tax
-2,266.67%-71K
-257.14%-25K
40.54%-22K
98.57%-44K
100.37%3K
99.50%-3K
99.38%-7K
92.83%-37K
31.22%-3.08M
59.39%-820K
Net income
-79.25%-14.57M
-24.69%-21.13M
-26.66%-19.66M
16.70%-61.18M
-19.09%-20.59M
42.39%-8.13M
28.88%-16.94M
14.83%-15.52M
-1,480.32%-73.45M
18.30%-17.29M
Net income continuous Operations
-79.25%-14.57M
-24.69%-21.13M
-26.66%-19.66M
16.70%-61.18M
-19.09%-20.59M
42.39%-8.13M
28.88%-16.94M
14.83%-15.52M
-1,480.32%-73.45M
18.30%-17.29M
Minority interest income
66.67%-5K
83.33%-2K
67.74%-10K
-9.00%-109K
-1,800.00%-51K
60.53%-15K
45.45%-12K
27.91%-31K
-376.19%-100K
-88.46%3K
Net income attributable to the parent company
-79.52%-14.57M
-24.77%-21.12M
-26.85%-19.65M
16.73%-61.07M
-18.78%-20.54M
42.34%-8.11M
28.87%-16.93M
14.80%-15.49M
-1,473.03%-73.35M
18.39%-17.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-79.52%-14.57M
-24.77%-21.12M
-26.85%-19.65M
16.73%-61.07M
-18.78%-20.54M
42.34%-8.11M
28.87%-16.93M
14.80%-15.49M
-1,473.03%-73.35M
18.39%-17.29M
Basic earnings per share
-71.43%-0.36
-20.93%-0.52
-22.50%-0.49
18.85%-1.55
-13.33%-0.51
43.24%-0.21
30.65%-0.43
16.67%-0.4
-1,464.29%-1.91
21.05%-0.45
Diluted earnings per share
-71.43%-0.36
-20.93%-0.52
-22.50%-0.49
18.85%-1.55
-13.33%-0.51
43.24%-0.21
30.65%-0.43
16.67%-0.4
-1,464.29%-1.91
21.05%-0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0001,766.46%14.97M014.97M00-98.21%802K0
Operating revenue --0--0--01,766.46%14.97M--0--14.97M--0--0-98.21%802K--0
Cost of revenue
Gross profit
Operating expense -57.21%10.16M24.95%21.98M24.38%20.3M-17.85%66.75M-53.24%9.09M59.34%23.74M-32.62%17.59M-21.52%16.32M71.05%81.26M-38.18%19.45M
Selling and administrative expenses -61.51%5.17M113.64%15.38M110.86%12.64M-25.53%29.67M-77.56%3.06M1,296.46%13.42M-45.15%7.2M-50.62%5.99M523.12%39.84M-29.69%13.62M
-General and administrative expense -61.51%5.17M113.64%15.38M110.86%12.64M-25.53%29.67M-77.56%3.06M1,296.46%13.42M-45.15%7.2M-50.62%5.99M523.12%39.84M-29.69%13.62M
Research and development costs -51.10%5.15M-39.73%6.61M-24.15%7.99M-7.63%38.25M6.67%6.22M-24.45%10.53M-15.52%10.97M21.65%10.53M0.74%41.41M-51.77%5.83M
Other operating expenses 25.71%-156K97.75%-13K-60.49%-329K---1.18M---184K---210K---577K---205K--------
Operating profit -15.81%-10.16M-24.95%-21.98M-24.38%-20.3M35.64%-51.78M53.24%-9.09M41.13%-8.77M31.75%-17.59M19.71%-16.32M-2,772.30%-80.45M22.22%-19.45M
Net non-operating interest income expense -25.24%459K-17.98%511K-28.83%543K-7.86%2.63M10.82%625K224.87%614K22.64%623K-51.95%763K-7.62%2.85M-56.78%564K
Non-operating interest income -25.20%472K-17.64%523K-28.26%556K-6.92%2.68M11.56%637K221.94%631K21.65%635K-51.20%775K-7.28%2.88M-56.87%571K
Non-operating interest expense -23.53%13K0.00%12K8.33%13K89.29%53K71.43%12K142.86%17K-14.29%12K--12K47.37%28K--7K
Other net income (expense) -19,107.69%-4.94M1,500.00%320K75K-1,215.90%-12.07M-1,665.89%-12.12M1,400.00%26K-93.55%20K90.83%1.08M50.00%774K
Special income (charges) ---4.67M-----------12.21M---12.21M--0----------0----
-Less:Impairment of capital assets --4.67M----------12.21M--12.21M--0----------0----
Other non- operating income (expenses) -1,157.69%-275K1,500.00%320K--75K-87.52%135K-88.50%89K1,400.00%26K-93.55%20K----90.83%1.08M50.00%774K
Income before tax -80.05%-14.64M-24.78%-21.15M-26.50%-19.68M19.99%-61.23M-13.68%-20.59M44.73%-8.13M32.09%-16.95M16.98%-15.56M-9,102.59%-76.52M21.88%-18.11M
Income tax -2,266.67%-71K-257.14%-25K40.54%-22K98.57%-44K100.37%3K99.50%-3K99.38%-7K92.83%-37K31.22%-3.08M59.39%-820K
Net income -79.25%-14.57M-24.69%-21.13M-26.66%-19.66M16.70%-61.18M-19.09%-20.59M42.39%-8.13M28.88%-16.94M14.83%-15.52M-1,480.32%-73.45M18.30%-17.29M
Net income continuous Operations -79.25%-14.57M-24.69%-21.13M-26.66%-19.66M16.70%-61.18M-19.09%-20.59M42.39%-8.13M28.88%-16.94M14.83%-15.52M-1,480.32%-73.45M18.30%-17.29M
Minority interest income 66.67%-5K83.33%-2K67.74%-10K-9.00%-109K-1,800.00%-51K60.53%-15K45.45%-12K27.91%-31K-376.19%-100K-88.46%3K
Net income attributable to the parent company -79.52%-14.57M-24.77%-21.12M-26.85%-19.65M16.73%-61.07M-18.78%-20.54M42.34%-8.11M28.87%-16.93M14.80%-15.49M-1,473.03%-73.35M18.39%-17.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -79.52%-14.57M-24.77%-21.12M-26.85%-19.65M16.73%-61.07M-18.78%-20.54M42.34%-8.11M28.87%-16.93M14.80%-15.49M-1,473.03%-73.35M18.39%-17.29M
Basic earnings per share -71.43%-0.36-20.93%-0.52-22.50%-0.4918.85%-1.55-13.33%-0.5143.24%-0.2130.65%-0.4316.67%-0.4-1,464.29%-1.9121.05%-0.45
Diluted earnings per share -71.43%-0.36-20.93%-0.52-22.50%-0.4918.85%-1.55-13.33%-0.5143.24%-0.2130.65%-0.4316.67%-0.4-1,464.29%-1.9121.05%-0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -